Open AccessProjecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age
Author(s) -
Éric Ouattara,
Xavier Anglaret,
Angela Y. Wong,
Jennifer Chu,
Heather Hsu,
Christine Danel,
Serge Eholié,
Raoul Moh,
Delphine Gabillard,
Rochelle P. Walensky,
Kenneth A. Freedberg
Publication year - 2012
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e328350fbfb
Subject(s) - nevirapine , efavirenz , medicine , obstetrics , cohort , reverse transcriptase inhibitor , cohort study , pediatrics , antiretroviral therapy , human immunodeficiency virus (hiv) , viral load , virology
To project the outcomes of using either efavirenz or nevirapine as part of initial antiretroviral therapy (ART) in women of childbearing age in Côte d'Ivoire.